MicroRNA-155 expression suggests a sex disparity in innate lymphoid cells at the single-cell level

[1]  G. Wennergren,et al.  Cohort profile: the West Sweden Asthma Study (WSAS): a multidisciplinary population-based longitudinal study of asthma, allergy and respiratory conditions in adults , 2019, BMJ Open.

[2]  J. Weidner,et al.  MicroRNAs in type 2 immunity. , 2018, Cancer letters.

[3]  E. Newell,et al.  Dissecting human ILC heterogeneity: more than just three subsets , 2018, Immunology.

[4]  A. V. van Zonneveld,et al.  Gender and cardiovascular disease: are sex-biased microRNA networks a driving force behind heart failure with preserved ejection fraction in women? , 2018, Cardiovascular research.

[5]  H. Kita,et al.  IL-33–Responsive Group 2 Innate Lymphoid Cells Are Regulated by Female Sex Hormones in the Uterus , 2018, The Journal of Immunology.

[6]  D. Stepniak,et al.  A sensitive flow cytometric method for multi-parametric analysis of microRNA, messenger RNA and protein in single cells. , 2017, Methods.

[7]  M. Rådinger,et al.  MicroRNA‐155 is a critical regulator of type 2 innate lymphoid cells and IL‐33 signaling in experimental models of allergic airway inflammation , 2017, The Journal of allergy and clinical immunology.

[8]  F. Liew,et al.  Interleukin-33 in health and disease , 2016, Nature Reviews Immunology.

[9]  A. Bossios,et al.  MicroRNA-155 is essential for T(H)2-mediated allergen-induced eosinophilic inflammation in the lung. , 2014, The Journal of allergy and clinical immunology.

[10]  P. Klenerman,et al.  Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells☆ , 2014, The Journal of allergy and clinical immunology.